Insufficient scRNA-seq data for expression of GPR52 at single-cell level.
Insufficient scRNA-seq data for expression of GPR52 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 77% | 59.99 | 2029 / 2642 | 7% | 0.14 | 52 / 705 |
| lung | 52% | 3.73 | 301 / 578 | 2% | 0.27 | 21 / 1155 |
| thymus | 54% | 3.76 | 350 / 653 | 0% | 0 | 0 / 605 |
| skin | 53% | 4.83 | 967 / 1809 | 0% | 0 | 0 / 472 |
| ovary | 53% | 3.71 | 95 / 180 | 0% | 0 | 0 / 430 |
| stomach | 49% | 11.73 | 175 / 359 | 3% | 0.27 | 10 / 286 |
| spleen | 46% | 2.94 | 110 / 241 | 0% | 0 | 0 / 0 |
| heart | 45% | 3.88 | 387 / 861 | 0% | 0 | 0 / 0 |
| adipose | 41% | 2.70 | 499 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 41% | 3.92 | 382 / 929 | 0% | 0 | 0 / 0 |
| esophagus | 40% | 2.60 | 575 / 1445 | 1% | 0.01 | 1 / 183 |
| bladder | 38% | 2.71 | 8 / 21 | 2% | 0.24 | 11 / 504 |
| uterus | 39% | 2.31 | 66 / 170 | 1% | 0.05 | 3 / 459 |
| intestine | 38% | 2.59 | 365 / 966 | 1% | 0.09 | 6 / 527 |
| breast | 37% | 2.48 | 171 / 459 | 1% | 0.14 | 15 / 1118 |
| prostate | 37% | 2.07 | 91 / 245 | 1% | 0.08 | 7 / 502 |
| blood vessel | 33% | 2.16 | 443 / 1335 | 0% | 0 | 0 / 0 |
| kidney | 26% | 1.48 | 23 / 89 | 1% | 0.07 | 6 / 901 |
| liver | 25% | 1.41 | 56 / 226 | 0% | 0 | 0 / 406 |
| adrenal gland | 18% | 0.85 | 46 / 258 | 0% | 0 | 0 / 230 |
| muscle | 18% | 0.89 | 142 / 803 | 0% | 0 | 0 / 0 |
| pancreas | 16% | 0.74 | 53 / 328 | 1% | 0.15 | 2 / 178 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0009410 | Biological process | response to xenobiotic stimulus |
| GO_0009584 | Biological process | detection of visible light |
| GO_0007602 | Biological process | phototransduction |
| GO_0007626 | Biological process | locomotory behavior |
| GO_0071482 | Biological process | cellular response to light stimulus |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0008020 | Molecular function | G protein-coupled photoreceptor activity |
| GO_0004930 | Molecular function | G protein-coupled receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | GPR52 |
| Protein name | G protein-coupled receptor 52 G-protein coupled receptor 52 |
| Synonyms | hCG_1648322 |
| Description | FUNCTION: Gs-coupled receptor activated by antipsychotics reserpine leading to an increase in intracellular cAMP and its internalization . May play a role in locomotor activity through modulation of dopamine, NMDA and ADORA2A-induced locomotor activity. These behavioral changes are accompanied by modulation of the dopamine receptor signaling pathway in striatum . Modulates HTT level via cAMP-dependent but PKA independent mechanisms throught activation of RAB39B that translocates HTT to the endoplasmic reticulum, thus avoiding proteasome degradation . . |
| Accessions | F2YGU0 ENST00000367685.5 Q9Y2T5 |